Review: could Cabergoline cause Intermenstrual bleeding?
This is a review of Intermenstrual bleeding (Vaginal bleeding between periods) by studying 2,157 people who take Cabergoline. We analyze: the time on Cabergoline when people have Intermenstrual bleeding, age of these people, the severity of Intermenstrual bleeding, how they recovered, and common conditions and drugs used besides Cabergoline. The review is created by eHealthMe based on reports from FDA and social media, and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. We use data reported since 1977 till to date. All studies are personalized to gender and age. Start now >>>
Cabergoline (latest outcomes from 2,340 users) has active ingredients of cabergoline. It is often used in prolactinoma, pituitary tumour. Commonly reported side effects of Cabergoline include mitral valve incompetence, pleural effusion, aortic valve incompetence, cardiac failure, hallucinations.
Intermenstrual bleeding (latest reports from 57,106 patients) has been reported by people with birth control, depression, menorrhagia, endometriosis, menstruation irregular.
On Mar, 7, 2014: 2,157 people reported to have side effects when taking Cabergoline. Among them, 2 people (0.09%) have Intermenstrual Bleeding. They amount to 0.00% of all the 57,105 people who have Intermenstrual Bleeding.
Time on Cabergoline when people have Intermenstrual bleeding * :
Age of people who have Intermenstrual bleeding when taking Cabergoline * :
|Intermenstrual bleeding||0.00%||0.00%||0.00%||0.00%||50.00%||50.00%||0.00%||0.00% |
Severity of Intermenstrual bleeding when taking Cabergoline ** :
How people recovered from Intermenstrual bleeding ** :
Top conditions involved for these people * :
- Neoplasm (1 people, 50.00%)
- Prolactin-producing pituitary tumour (1 people, 50.00%)
Top co-used drugs for these people * :n/a
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Cabergoline, Intermenstrual bleeding
You can also:
On eHealthMe, Cabergoline (cabergoline) is often used for prolactinoma. Find out below the conditions Cabergoline is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Cabergoline used for and how effective is it:
Other drugs that are used to treat the same conditions:
Browse Cabergoline side effects from A to Z:
Browse Cabergoline drug interactions with drugs from A to Z:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (2 days ago):
I have PCOS possible Endometriosis, bleeding while on TRANEXAMIC and CONTRACEPTION. ferritin levels increase (minor)
From this study (1 week ago):
I have been under a lot of stress lately more than ever.
From this study (2 months ago):
endometrial thickness decreased considerably, as well as menstrual flow and days of bleeding. In the 7th month since Mirena was inserted, intermenstrual spotting began on day 9 and still lasts. Today is day 17.
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Cabergoline, Intermenstrual bleeding
You may be interested at these reviews (what is this?):
More reviews for: Cabergoline, Intermenstrual bleeding
Related drug studies for: Cabergoline, Intermenstrual bleeding
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.